Chromosomal instability drives metastasis through a cytosolic DNA response
Chromosomal instability is a hallmark of cancer that results from ongoing errors in chromosome
segregation during mitosis. Although chromosomal instability is a major driver of tumour …
segregation during mitosis. Although chromosomal instability is a major driver of tumour …
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility …
PURPOSE: Hypoxia renders tumor cells radioresistant, limiting locoregional control from
radiotherapy (RT). Intensity-modulated RT (IMRT) allows for targeting of the gross tumor volume …
radiotherapy (RT). Intensity-modulated RT (IMRT) allows for targeting of the gross tumor volume …
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and …
Background Chemoradiotherapy is the standard of care for unresected locally advanced
squamous cell carcinoma of the head and neck. We aimed to assess if addition of avelumab (…
squamous cell carcinoma of the head and neck. We aimed to assess if addition of avelumab (…
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer
Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer.
Rapid evaluation and establishment of treatment goals are imperative for optimum patient …
Rapid evaluation and establishment of treatment goals are imperative for optimum patient …
The abscopal effect associated with a systemic anti-melanoma immune response
EF Stamell, JD Wolchok, S Gnjatic, NY Lee… - International Journal of …, 2013 - Elsevier
The clearance of nonirradiated tumors after localized radiation therapy is known as the
abscopal effect. Activation of an antitumor immune response has been proposed as a …
abscopal effect. Activation of an antitumor immune response has been proposed as a …
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience
Purpose: To review the Memorial Sloan-Kettering Cancer Center’s experience in using
intensity-modulated radiation therapy (IMRT) for the treatment of oropharyngeal cancer. Methods …
intensity-modulated radiation therapy (IMRT) for the treatment of oropharyngeal cancer. Methods …
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer
SC Ong, H Schöder, NY Lee, SG Patel… - Journal of Nuclear …, 2008 - Soc Nuclear Med
For patients with locoregional advanced head and neck squamous cell carcinoma (HNSCC),
concurrent chemoradiotherapy is a widely accepted treatment, but the need for subsequent …
concurrent chemoradiotherapy is a widely accepted treatment, but the need for subsequent …
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal
sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and …
sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and …
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
Abstract Treatment with immune checkpoint inhibitors (ICI) has demonstrated clinical benefit
for a wide range of cancer types. Because only a subset of patients experience clinical …
for a wide range of cancer types. Because only a subset of patients experience clinical …
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
Background We aimed to improve the outcomes for locoregionally advanced nasopharyngeal
carcinoma by testing the feasibility and safety of the addition of bevacizumab to …
carcinoma by testing the feasibility and safety of the addition of bevacizumab to …